Hailiang Wei
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Circular RNAs in diseases 4
- RNA modifications and cancer 1
-
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 3
- Co-authors
- Shuguang Yan (16 shared papers)Hui Guo (2 shared papers)Jiaxiang Zhang (5 shared papers)Yonggang Liu (2 shared papers)Jingtao Li (3 shared papers)Qian Li (1 shared paper)Yan Liang (3 shared papers)Yingjun Guo (1 shared paper)
In The Last Decade
Hailiang Wei
22 papers receiving 329 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 85
- Molecular Medicine 17
- Pharmacology 28
- Molecular Biology 136
- General Energy 2
Countries citing papers authored by Hailiang Wei
This map shows the geographic impact of Hailiang Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hailiang Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hailiang Wei more than expected).
Fields of papers citing papers by Hailiang Wei
This network shows the impact of papers produced by Hailiang Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hailiang Wei. The network helps show where Hailiang Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Hailiang Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 40 | |
| 2 | 2020 | 39 | |
| 3 | 2022 | 35 | |
| 4 | 2022 | 32 | |
| 5 | 2020 | 27 | |
| 6 | 2021 | 23 | |
| 7 | 2020 | 23 | |
| 8 | 2020 | 21 | |
| 9 | 2025 | 15 | |
| 10 | 2020 | 14 | |
| 11 | 2024 | 10 | |
| 12 | 2023 | 10 | |
| 13 | 2022 | 8 | |
| 14 | 2023 | 7 | |
| 15 | 2019 | 6 | |
| 16 | 2020 | 5 | |
| 17 | 2022 | 5 | |
| 18 | 2023 | 4 | |
| 19 | 2022 | 3 | |
| 20 | 2022 | 3 |
About Hailiang Wei
Hailiang Wei is a scholar working on Molecular Biology, Cancer Research, Immunology, Epidemiology and Oncology, having authored 23 papers that have together received 332 indexed citations. Recurring topics across this work include Circular RNAs in diseases (4 papers), Liver Disease Diagnosis and Treatment (3 papers), MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (3 papers), Inflammatory Bowel Disease (2 papers), IL-33, ST2, and ILC Pathways (2 papers), Immune cells in cancer (2 papers) and RNA modifications and cancer (1 paper). The work is most often cited by research in Cancer Research (85 citations), Molecular Medicine (17 citations), Pharmacology (28 citations), Molecular Biology (136 citations) and General Energy (2 citations). Hailiang Wei has collaborated with scholars based in China, Japan and Canada. Frequent co-authors include Shuguang Yan, Hui Guo, Jiaxiang Zhang, Yonggang Liu, Jingtao Li, Qian Li, Yan Liang, Yingjun Guo, Xiaofan Xu and Ting Chen. Their work appears in journals such as Cellular Signalling, Frontiers in Nutrition, Pharmaceutical Biology, Journal of Ethnopharmacology and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.